People with one albinism gene mutation may be prone to pale-colored melanomas

People with pale-colored melanomas are more likely to have a gene mutation associated with albinism, University of Queensland research has found.

Study lead author Dr Jenna Rayner said albinism, a rare genetic disorder affecting one in 10,000 people, prevented brown pigment from being synthesized in the body and led to fair hair and extremely pale skin that was easily sunburned and prone to skin cancers.

Albinism develops when there are two mutated genes, so people with one mutation usually don't know they have it.

These people may be more prone to developing pale-colored melanomas, called amelanotic, because tumors accumulate new mutations, and they already have a mutated albinism gene."

Dr Jenna Rayner, Study Lead Author

The researchers studied DNA samples from more than 380 volunteers using whole-exome sequencing, while looking for rare genetic mutations that cause albinism.

Queensland has the highest rate of melanoma in the world and more than 14,000 cases are diagnosed in Australia each year.

UQ Dermatology Research Centre Associate Professor Rick Sturm said up to eight per cent of melanomas could be amelanotic, making them difficult to diagnose and easily mistaken for non-cancerous conditions like warts or scars.

"Amelanotic melanomas are normally diagnosed in advanced stage, compared with darker melanomas, causing patients to often miss out on early treatment and their best chance of a cure," he said.

When funding becomes available, researchers plan to collect amelanotic melanoma samples to compare their genotype with that of the patient.

Dr Rayner said it could lead to personalized medicine - where doctors would be alerted to monitor potential amelanotic melanomas in people with one albinism gene mutation.

"This could optimize early intervention and consequently improve patient outcomes," she said.

Journal reference:

Rayner, J.E., et al. (2020) Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants. PLOS ONE.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
RNA regulatory mechanism could be targeted to slow AD progression mediated by stress granules